6:11 AM ET
8-K
Regulatory Approval
Lipocine Regulatory Approval
Lipocine announced that Health Canada has approved TLANDO (testosterone undecanoate) capsules for testosterone replacement therapy in adult males. The product is licensed to Verity Pharmaceuticals, which plans to launch and commercialize the oral therapeutic in the Canadian market by the end of 2026.
- Counterparty
- Health Canada